{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:51:14Z","timestamp":1790664674375,"version":"4.1.0"},"reference-count":141,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001655","name":"DAAD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001655","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.virol.2021.01.017","type":"journal-article","created":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T16:54:14Z","timestamp":1612457654000},"page":"1-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Murine leukemia virus resists producer cell APOBEC3A by its Glycosylated Gag but not target cell APOBEC3A"],"prefix":"10.1016","volume":"557","author":[{"given":"Ananda Ayyappan","family":"Jaguva Vasudevan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kannan","family":"Balakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Franken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Krikoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"H\u00e4ussinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Luedde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"M\u00fcnk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2021.01.017_bib1","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1074\/jbc.M706436200","article-title":"Vpr.A3A chimera inhibits HIV replication","volume":"283","author":"Aguiar","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2021.01.017_bib2","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01985-16","article-title":"Functional interplay between murine leukemia virus glycogag, Serinc5, and surface glycoprotein governs virus entry, with opposite effects on gammaretroviral and ebolavirus glycoproteins","volume":"7","author":"Ahi","year":"2016","journal-title":"mBio"},{"key":"10.1016\/j.virol.2021.01.017_bib3","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/icb.2015.53","article-title":"Modulating APOBEC expression enhances DNA vaccine immunogenicity","volume":"93","author":"Almeida","year":"2015","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.virol.2021.01.017_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.virol.2015.10.034","article-title":"Interferon but not MxB inhibits foamy retroviruses","volume":"488","author":"B\u00e4hr","year":"2016","journal-title":"Virology"},{"issue":"Suppl. 1","key":"10.1016\/j.virol.2021.01.017_bib5","article-title":"Retroviral vectors: new applications for an old tool","volume":"11","author":"Barquinero","year":"2004","journal-title":"Gene Ther."},{"key":"10.1016\/j.virol.2021.01.017_bib6","doi-asserted-by":"crossref","first-page":"12248","DOI":"10.1074\/jbc.M109.090977","article-title":"Interaction of Vpx and apolipoprotein B mRNA-editing catalytic polypeptide 3 family member A (APOBEC3A) correlates with efficient lentivirus infection of monocytes","volume":"285","author":"Berger","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2021.01.017_bib7","doi-asserted-by":"crossref","first-page":"e1002425","DOI":"10.1371\/journal.ppat.1002425","article-title":"SAMHD1-deficient CD14+ cells from individuals with Aicardi-Goutieres syndrome are highly susceptible to HIV-1 infection","volume":"7","author":"Berger","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2021.01.017_bib8","doi-asserted-by":"crossref","first-page":"e1002221","DOI":"10.1371\/journal.ppat.1002221","article-title":"APOBEC3A is a specific inhibitor of the early phases of HIV-1 infection in myeloid cells","volume":"7","author":"Berger","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2021.01.017_bib9","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1128\/jvi.69.4.2214-2222.1995","article-title":"An internal ribosomal entry mechanism promotes translation of murine leukemia virus gag polyprotein precursors","volume":"69","author":"Berlioz","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2021.01.017_bib10","doi-asserted-by":"crossref","first-page":"8450","DOI":"10.1128\/JVI.00839-06","article-title":"Antiviral potency of APOBEC proteins does not correlate with cytidine deamination","volume":"80","author":"Bishop","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2021.01.017_bib11","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.cub.2004.06.057","article-title":"Cytidine deamination of retroviral DNA by diverse APOBEC proteins","volume":"14","author":"Bishop","year":"2004","journal-title":"Curr. Biol."},{"key":"10.1016\/j.virol.2021.01.017_bib12","doi-asserted-by":"crossref","first-page":"e1000231","DOI":"10.1371\/journal.ppat.1000231","article-title":"APOBEC3G inhibits elongation of HIV-1 reverse transcripts","volume":"4","author":"Bishop","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2021.01.017_bib13","doi-asserted-by":"crossref","first-page":"341294","DOI":"10.1155\/2011\/341294","article-title":"Phylogeny-directed search for murine leukemia virus-like retroviruses in vertebrate genomes and in patients suffering from myalgic encephalomyelitis\/chronic fatigue syndrome and prostate cancer","volume":"2011","author":"Blomberg","year":"2011","journal-title":"Adv. Virol."},{"key":"10.1016\/j.virol.2021.01.017_bib14","doi-asserted-by":"crossref","first-page":"7422","DOI":"10.1128\/JVI.74.16.7422-7430.2000","article-title":"Use of a transient assay for studying the genetic determinants of Fv1 restriction","volume":"74","author":"Bock","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2021.01.017_bib15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/nar\/gkj416","article-title":"APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells","volume":"34","author":"Bogerd","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.virol.2021.01.017_bib16","doi-asserted-by":"crossref","first-page":"8780","DOI":"10.1073\/pnas.0603313103","article-title":"Cellular inhibitors of long interspersed element 1 and Alu retrotransposition","volume":"103","author":"Bogerd","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virol.2021.01.017_bib17","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.jmb.2011.03.058","article-title":"Multifaceted counter-APOBEC3G mechanisms employed by HIV-1 Vif","volume":"410","author":"Britan-Rosich","year":"2011","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.virol.2021.01.017_bib18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.virol.2009.02.026","article-title":"Restriction of HIV-1 by APOBEC3G is cytidine deaminase-dependent","volume":"387","author":"Browne","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.virol.2021.01.017_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw2872","article-title":"Passenger hotspot mutations in cancer driven by APOBEC3A and mesoscale genomic features","volume":"364","author":"Buisson","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.virol.2021.01.017_bib20","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1128\/JVI.01651-10","article-title":"Structure-function analyses point to a polynucleotide-accommodating groove essential for APOBEC3A restriction activities","volume":"85","author":"Bulliard","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2021.01.017_bib21","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/nature11881","article-title":"APOBEC3B is an enzymatic source of mutation in breast cancer","volume":"494","author":"Burns","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.virol.2021.01.017_bib22","doi-asserted-by":"crossref","first-page":"34801","DOI":"10.1074\/jbc.M112.385161","article-title":"Methylcytosine and normal cytosine deamination by the foreign DNA restriction enzyme APOBEC3A","volume":"287","author":"Carpenter","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2021.01.017_bib23","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1097\/QAD.0b013e328361d059","article-title":"M1 polarization of human monocyte-derived macrophages restricts pre and postintegration steps of HIV-1 replication","volume":"27","author":"Cassetta","year":"2013","journal-title":"AIDS"},{"key":"10.1016\/j.virol.2021.01.017_bib24","doi-asserted-by":"crossref","first-page":"13197","DOI":"10.1073\/pnas.1612044113","article-title":"S2 from equine infectious anemia virus is an infectivity factor which counteracts the retroviral inhibitors SERINC5 and SERINC3","volume":"113","author":"Chande","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virol.2021.01.017_bib25","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.cub.2006.01.031","article-title":"APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons","volume":"16","author":"Chen","year":"2006","journal-title":"Curr. Biol."},{"key":"10.1016\/j.virol.2021.01.017_bib26","doi-asserted-by":"crossref","first-page":"3857","DOI":"10.1128\/jvi.68.6.3857-3867.1994","article-title":"A nonstructural gag-encoded glycoprotein precursor is necessary for efficient spreading and pathogenesis of murine leukemia viruses","volume":"68","author":"Corbin","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2021.01.017_bib27","doi-asserted-by":"crossref","first-page":"e1008545","DOI":"10.1371\/journal.pgen.1008545","article-title":"APOBEC3A is a prominent cytidine deaminase in breast cancer","volume":"15","author":"Cortez","year":"2019","journal-title":"PLoS Genet."},{"key":"10.1016\/j.virol.2021.01.017_bib28","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1128\/JVI.74.2.846-850.2000","article-title":"Characterization of an internal ribosomal entry segment in the 5' leader of murine leukemia virus env RNA","volume":"74","author":"Deffaud","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2021.01.017_bib29","doi-asserted-by":"crossref","first-page":"8201","DOI":"10.1128\/JVI.79.13.8201-8207.2005","article-title":"Differential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion","volume":"79","author":"Doehle","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2021.01.017_bib30","doi-asserted-by":"crossref","first-page":"3842","DOI":"10.1128\/JVI.01880-10","article-title":"Restriction of porcine endogenous retrovirus by porcine APOBEC3 cytidine deaminases","volume":"85","author":"D\u00f6rrschuck","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2021.01.017_bib31","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","article-title":"A third-generation lentivirus vector with a conditional packaging system","volume":"72","author":"Dull","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2021.01.017_bib32","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1128\/jvi.30.2.551-563.1979","article-title":"gag-Related polyproteins of Moloney murine leukemia virus: evidence for independent synthesis of glycosylated and unglycosylated forms","volume":"30","author":"Edwards","year":"1979","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2021.01.017_bib33","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cellsig.2014.12.016","article-title":"Oncostatin M regulates SOCS3 mRNA stability via the MEK-ERK1\/2-pathway independent of p38(MAPK)\/MK2","volume":"27","author":"Ehlting","year":"2015","journal-title":"Cell. Signal."},{"key":"10.1016\/j.virol.2021.01.017_bib34","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1128\/jvi.24.3.865-874.1977","article-title":"Synthesis and glycosylation of polyprotein precursors to the internal core proteins of Friend murine leukemia virus","volume":"24","author":"Evans","year":"1977","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2021.01.017_bib35","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1742-4690-4-61","article-title":"Targeting APOBEC3A to the viral nucleoprotein complex confers antiviral activity","volume":"4","author":"Goila-Gaur","year":"2007","journal-title":"Retrovirology"},{"key":"10.1016\/j.virol.2021.01.017_bib36","doi-asserted-by":"crossref","first-page":"102700","DOI":"10.1016\/j.dnarep.2019.102700","article-title":"The spectrum of APOBEC3 activity: from anti-viral agents to anti-cancer opportunities","volume":"83","author":"Green","year":"2019","journal-title":"DNA Repair"},{"key":"10.1016\/j.virol.2021.01.017_bib37","doi-asserted-by":"crossref","first-page":"11322","DOI":"10.1128\/JVI.00162-07","article-title":"The interaction of APOBEC3G with human immunodeficiency virus type 1 nucleocapsid inhibits tRNA3Lys annealing to viral RNA","volume":"81","author":"Guo","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2021.01.017_bib38","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0092-8674(03)00423-9","article-title":"DNA deamination mediates innate immunity to retroviral infection","volume":"113","author":"Harris","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.virol.2021.01.017_bib39","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.virol.2015.03.012","article-title":"APOBECs and virus restriction","volume":"479\u2013480","author":"Harris","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.virol.2021.01.017_bib40","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.molmed.2015.02.007","article-title":"APOBEC3 genes: retroviral restriction factors to cancer drivers","volume":"21","author":"Henderson","year":"2015","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.virol.2021.01.017_bib41","doi-asserted-by":"crossref","first-page":"e4277","DOI":"10.1371\/journal.pone.0004277","article-title":"Genetic editing of HBV DNA by monodomain human APOBEC3 cytidine deaminases and the recombinant nature of APOBEC3G","volume":"4","author":"Henry","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2021.01.017_bib42","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1074\/jbc.M607298200","article-title":"APOBEC3F can inhibit the accumulation of HIV-1 reverse transcription products in the absence of hypermutation. Comparisons with APOBEC3G","volume":"282","author":"Holmes","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2021.01.017_bib43","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1038\/nature10195","article-title":"Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein","volume":"474","author":"Hrecka","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.virol.2021.01.017_bib44","doi-asserted-by":"crossref","first-page":"11220","DOI":"10.1128\/JVI.05238-11","article-title":"Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1","volume":"85","author":"Hultquist","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2021.01.017_bib45","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1073\/pnas.1914183116","article-title":"Retroviruses drive the rapid evolution of mammalian APOBEC3 genes","volume":"117","author":"Ito","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virol.2021.01.017_bib46","doi-asserted-by":"crossref","first-page":"7096","DOI":"10.1093\/nar\/gkm750","article-title":"Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G","volume":"35","author":"Iwatani","year":"2007","journal-title":"Nucleic Acids Res."},{"issue":"23","key":"10.1016\/j.virol.2021.01.017_bib47","doi-asserted-by":"crossref","first-page":"6200","DOI":"10.1016\/j.jmb.2020.10.014","article-title":"Loop 1 of APOBEC3C regulates its antiviral activity against HIV-1","volume":"432","author":"Jaguva Vasudevan","year":"2020","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.virol.2021.01.017_bib48","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/978-1-4939-7234-0_8","article-title":"Detection of APOBEC3 proteins and catalytic activity in urothelial carcinoma","volume":"1655","author":"Jaguva Vasudevan","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.virol.2021.01.017_bib49","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.jmb.2017.03.015","article-title":"Enhancing the catalytic deamination activity of APOBEC3C is insufficient to inhibit vif-deficient HIV-1","volume":"429","author":"Jaguva Vasudevan","year":"2017","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.virol.2021.01.017_bib50","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.3389\/fmicb.2018.02088","article-title":"APOBEC3B activity is prevalent in urothelial carcinoma cells and only slightly affected by LINE-1 expression","volume":"9","author":"Jaguva Vasudevan","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.virol.2021.01.017_bib51","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1006\/geno.2002.6718","article-title":"An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22","volume":"79","author":"Jarmuz","year":"2002","journal-title":"Genomics"},{"key":"10.1016\/j.virol.2021.01.017_bib52","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1128\/JVI.80.3.1152-1159.2006","article-title":"Transduction of nondividing human macrophages with gammaretrovirus-derived vectors","volume":"80","author":"Jarrosson-Wuilleme","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2021.01.017_bib53","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1002\/ijc.32500","article-title":"Expression of estrogen receptor alpha is associated with pathogenesis and prognosis of human papillomavirus-positive oropharyngeal cancer","volume":"145","author":"Kano","year":"2019","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.virol.2021.01.017_bib54","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.virol.2007.08.005","article-title":"Production of infectious virus and degradation of APOBEC3G are separable functional properties of human immunodeficiency virus type 1 Vif","volume":"369","author":"Kao","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.virol.2021.01.017_bib55","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1742-4690-1-27","article-title":"Production of infectious human immunodeficiency virus type 1 does not require depletion of APOBEC3G from virus-producing cells","volume":"1","author":"Kao","year":"2004","journal-title":"Retrovirology"},{"key":"10.1016\/j.virol.2021.01.017_bib56","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.virol.2010.01.021","article-title":"Inhibition of LINE-1 and Alu retrotransposition by exosomes encapsidating APOBEC3G and APOBEC3F","volume":"400","author":"Khatua","year":"2010","journal-title":"Virology"},{"key":"10.1016\/j.virol.2021.01.017_bib57","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1128\/JVI.72.2.994-1004.1998","article-title":"Construction of retroviral vectors with improved safety, gene expression, and versatility","volume":"72","author":"Kim","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2021.01.017_bib58","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1093\/nar\/gkm181","article-title":"All APOBEC3 family proteins differentially inhibit LINE-1 retrotransposition","volume":"35","author":"Kinomoto","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.virol.2021.01.017_bib59","doi-asserted-by":"crossref","first-page":"10933","DOI":"10.1128\/JVI.01023-10","article-title":"The glycosylated Gag protein of a murine leukemia virus inhibits the antiretroviral function of APOBEC3","volume":"84","author":"Kolokithas","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2021.01.017_bib60","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1038\/onc.2016.335","article-title":"APOBEC3A associates with human papillomavirus genome integration in oropharyngeal cancers","volume":"36","author":"Kondo","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.virol.2021.01.017_bib61","doi-asserted-by":"crossref","first-page":"13448","DOI":"10.1128\/JVI.00775-11","article-title":"Target cell-mediated editing of HIV-1 cDNA by APOBEC3 proteins in human macrophages","volume":"85","author":"Koning","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2021.01.017_bib62","doi-asserted-by":"crossref","first-page":"9474","DOI":"10.1128\/JVI.01089-09","article-title":"Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets","volume":"83","author":"Koning","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2021.01.017_bib63","doi-asserted-by":"crossref","first-page":"8824","DOI":"10.1128\/JVI.73.10.8824-8830.1999","article-title":"Association of Nef with the human immunodeficiency virus type 1 core","volume":"73","author":"Kotov","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2021.01.017_bib64","doi-asserted-by":"crossref","first-page":"762","DOI":"10.4161\/cc.23713","article-title":"Subcellular localization of the APOBEC3 proteins during mitosis and implications for genomic DNA deamination","volume":"12","author":"Lackey","year":"2013","journal-title":"Cell Cycle"},{"key":"10.1016\/j.virol.2021.01.017_bib65","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/nature10117","article-title":"SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx","volume":"474","author":"Laguette","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.virol.2021.01.017_bib66","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/ni.2236","article-title":"SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates","volume":"13","author":"Lahouassa","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.virol.2021.01.017_bib67","doi-asserted-by":"crossref","first-page":"17253","DOI":"10.1074\/jbc.M113.458661","article-title":"Endogenous APOBEC3A DNA cytosine deaminase is cytoplasmic and nongenotoxic","volume":"288","author":"Land","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2021.01.017_bib68","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/embor.2011.46","article-title":"APOBEC3A can activate the DNA damage response and cause cell-cycle arrest","volume":"12","author":"Landry","year":"2011","journal-title":"EMBO Rep."},{"key":"10.1016\/j.virol.2021.01.017_bib69","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1128\/JVI.01976-08","article-title":"Guidelines for naming nonprimate APOBEC3 genes and proteins","volume":"83","author":"LaRue","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2021.01.017_bib70","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200261","article-title":"APOBEC3A catalyzes mutation and drives carcinogenesis in vivo","volume":"217","author":"Law","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virol.2021.01.017_bib71","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1126\/science.1083338","article-title":"Hypermutation of HIV-1 DNA in the absence of the Vif protein","volume":"300","author":"Lecossier","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.virol.2021.01.017_bib72","doi-asserted-by":"crossref","first-page":"32065","DOI":"10.1074\/jbc.M703423200","article-title":"APOBEC3G inhibits DNA strand transfer during HIV-1 reverse transcription","volume":"282","author":"Li","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2021.01.017_bib73","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1073\/pnas.1114981109","article-title":"Systematic identification of type I and type II interferon-induced antiviral factors","volume":"109","author":"Liu","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virol.2021.01.017_bib74","doi-asserted-by":"crossref","first-page":"e97062","DOI":"10.1371\/journal.pone.0097062","article-title":"A DNA sequence recognition loop on APOBEC3A controls substrate specificity","volume":"9","author":"Logue","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2021.01.017_bib75","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1749-6632.2009.05006.x","article-title":"APOBEC3 proteins inhibit LINE-1 retrotransposition in the absence of ORF1p binding","volume":"1178","author":"Lovsin","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.virol.2021.01.017_bib76","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1128\/JVI.01538-06","article-title":"Mutation in the glycosylated gag protein of murine leukemia virus results in reduced in vivo infectivity and a novel defect in viral budding or release","volume":"81","author":"Low","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2021.01.017_bib77","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1126\/science.1243462","article-title":"Specific and nonhepatotoxic degradation of nuclear hepatitis B virus cccDNA","volume":"343","author":"Lucifora","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.virol.2021.01.017_bib78","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1093\/nar\/gkp030","article-title":"AID can restrict L1 retrotransposition suggesting a dual role in innate and adaptive immunity","volume":"37","author":"MacDuff","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.virol.2021.01.017_bib79","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3390\/v3060677","article-title":"Gammaretroviral vectors: biology, technology and application","volume":"3","author":"Maetzig","year":"2011","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2021.01.017_bib80","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nature01709","article-title":"Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts","volume":"424","author":"Mangeat","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.virol.2021.01.017_bib81","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0092-8674(03)00515-4","article-title":"Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif","volume":"114","author":"Mariani","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.virol.2021.01.017_bib83","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/nm946","article-title":"HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation","volume":"9","author":"Marin","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2021.01.017_bib84","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1128\/JVI.00272-07","article-title":"Human immunodeficiency virus type 1 cDNAs produced in the presence of APOBEC3G exhibit defects in plus-strand DNA transfer and integration","volume":"81","author":"Mbisa","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2021.01.017_bib85","doi-asserted-by":"crossref","first-page":"8270","DOI":"10.1128\/JVI.00670-09","article-title":"Truncation of TRIM5 in the Feliformia explains the absence of retroviral restriction in cells of the domestic cat","volume":"83","author":"McEwan","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2021.01.017_bib86","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.molcel.2019.07.018","article-title":"Poly(ADP-Ribose) polymerase 2 recruits replication protein A to sites of LINE-1 integration to facilitate retrotransposition","volume":"75","author":"Miyoshi","year":"2019","journal-title":"Mol. Cell."},{"key":"10.1016\/j.virol.2021.01.017_bib87","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.4049\/jimmunol.1201184","article-title":"IFN-alpha induces APOBEC3G, F, and A in immature dendritic cells and limits HIV-1 spread to CD4+ T cells","volume":"190","author":"Mohanram","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2021.01.017_bib88","doi-asserted-by":"crossref","first-page":"22161","DOI":"10.1074\/jbc.M601716200","article-title":"APOBEC3 proteins inhibit human LINE-1 retrotransposition","volume":"281","author":"Muckenfuss","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2021.01.017_bib89","doi-asserted-by":"crossref","DOI":"10.1186\/gb-2008-9-3-r48","article-title":"Functions, structure, and read-through alternative splicing of feline APOBEC3 genes","volume":"9","author":"M\u00fcnk","year":"2008","journal-title":"Genome Biol."},{"key":"10.1016\/j.virol.2021.01.017_bib90","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.3390\/v4113132","article-title":"Running loose or getting lost: how HIV-1 counters and capitalizes on APOBEC3-induced mutagenesis through its vif protein","volume":"4","author":"M\u00fcnk","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2021.01.017_bib91","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1471-2148-12-71","article-title":"An ancient history of gene duplications, fusions and losses in the evolution of APOBEC3 mutators in mammals","volume":"12","author":"M\u00fcnk","year":"2012","journal-title":"BMC Evol. Biol."},{"key":"10.1016\/j.virol.2021.01.017_bib92","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000439","article-title":"Deaminase-independent inhibition of parvoviruses by the APOBEC3A cytidine deaminase","volume":"5","author":"Narvaiza","year":"2009","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2021.01.017_bib93","doi-asserted-by":"crossref","first-page":"9577","DOI":"10.1128\/JVI.02800-06","article-title":"Differential inhibition of long interspersed element 1 by APOBEC3 does not correlate with high-molecular-mass-complex formation or P-body association","volume":"81","author":"Niewiadomska","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2021.01.017_bib94","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1073\/pnas.0908660107","article-title":"Murine leukemia virus glycosylated Gag (gPr80gag) facilitates interferon-sensitive virus release through lipid rafts","volume":"107","author":"Nitta","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virol.2021.01.017_bib95","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00341-10","article-title":"The cellular protein La functions in enhancement of virus release through lipid rafts facilitated by murine leukemia virus glycosylated Gag","volume":"2","author":"Nitta","year":"2011","journal-title":"mBio"},{"key":"10.1016\/j.virol.2021.01.017_bib96","doi-asserted-by":"crossref","first-page":"6097","DOI":"10.1128\/JVI.06570-11","article-title":"APOBEC3A, APOBEC3B, and APOBEC3H haplotype 2 restrict human T-lymphotropic virus type 1","volume":"86","author":"Ooms","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2021.01.017_bib97","doi-asserted-by":"crossref","first-page":"8236","DOI":"10.1128\/JVI.02694-06","article-title":"Human immunodeficiency virus type 1 Vif inhibits packaging and antiviral activity of a degradation-resistant APOBEC3G variant","volume":"81","author":"Opi","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2021.01.017_bib98","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1126\/science.1205292","article-title":"Recombinant origin of the retrovirus XMRV","volume":"333","author":"Paprotka","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.virol.2021.01.017_bib99","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1182\/blood-2006-10-051763","article-title":"Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression","volume":"110","author":"Peng","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.virol.2021.01.017_bib100","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1084\/jem.20051512","article-title":"Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity","volume":"203","author":"Peng","year":"2006","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virol.2021.01.017_bib101","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1128\/jvi.68.6.3879-3887.1994","article-title":"Identification of a sequence in the unique 5' open reading frame of the gene encoding glycosylated Gag which influences the incubation period of neurodegenerative disease induced by a murine retrovirus","volume":"68","author":"Portis","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2021.01.017_bib102","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0022-2836(89)90347-1","article-title":"CUG initiation codon used for the synthesis of a cell surface antigen coded by the murine leukemia virus","volume":"205","author":"Prats","year":"1989","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.virol.2021.01.017_bib103","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1093\/nar\/gkq174","article-title":"Quantitative profiling of the full APOBEC3 mRNA repertoire in lymphocytes and tissues: implications for HIV-1 restriction","volume":"38","author":"Refsland","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.virol.2021.01.017_bib104","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01530-17","article-title":"Full-length glycosylated gag of murine leukemia virus can associate with the viral envelope as a type I integral membrane protein","volume":"92","author":"Renner","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2021.01.017_bib105","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.02008","article-title":"APOBEC3A deaminates transiently exposed single-strand DNA during LINE-1 retrotransposition","volume":"3","author":"Richardson","year":"2014","journal-title":"Elife"},{"key":"10.1016\/j.virol.2021.01.017_bib106","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/ng.2702","article-title":"An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers","volume":"45","author":"Roberts","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.virol.2021.01.017_bib107","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nature15399","article-title":"HIV-1 Nef promotes infection by excluding SERINC5 from virion incorporation","volume":"526","author":"Rosa","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.virol.2021.01.017_bib108","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1128\/JVI.03330-14","article-title":"N-linked glycosylation protects gammaretroviruses against deamination by APOBEC3 proteins","volume":"89","author":"Rosales Gerpe","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2021.01.017_bib109","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/bioinformatics\/16.4.400","article-title":"Detecting hypermutations in viral sequences with an emphasis on G--> A hypermutation","volume":"16","author":"Rose","year":"2000","journal-title":"Bioinformatics"},{"key":"10.1016\/j.virol.2021.01.017_bib110","doi-asserted-by":"crossref","first-page":"8765","DOI":"10.1074\/jbc.M409309200","article-title":"HIV-1 Vif can directly inhibit apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G-mediated cytidine deamination by using a single amino acid interaction and without protein degradation","volume":"280","author":"Santa-Marta","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2021.01.017_bib111","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1006\/mthe.2000.0191","article-title":"Context dependence of different modules for posttranscriptional enhancement of gene expression from retroviral vectors","volume":"2","author":"Schambach","year":"2000","journal-title":"Mol. Ther."},{"key":"10.1016\/j.virol.2021.01.017_bib112","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.virol.2011.07.017","article-title":"Differential virus restriction patterns of rhesus macaque and human APOBEC3A: implications for lentivirus evolution","volume":"419","author":"Schmitt","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.virol.2021.01.017_bib113","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.virol.2013.04.002","article-title":"Lentivirus restriction by diverse primate APOBEC3A proteins","volume":"442","author":"Schmitt","year":"2013","journal-title":"Virology"},{"key":"10.1016\/j.virol.2021.01.017_bib114","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1038\/nm945","article-title":"The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif","volume":"9","author":"Sheehy","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2021.01.017_bib115","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1128\/jvi.69.7.4582-4586.1995","article-title":"Aberrant Gag protein composition of a human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes","volume":"69","author":"Simm","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2021.01.017_bib116","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/nar\/23.4.628","article-title":"A transient three-plasmid expression system for the production of high titer retroviral vectors","volume":"23","author":"Soneoka","year":"1995","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.virol.2021.01.017_bib117","doi-asserted-by":"crossref","first-page":"e1004145","DOI":"10.1371\/journal.ppat.1004145","article-title":"Different modes of retrovirus restriction by human APOBEC3A and APOBEC3G in vivo","volume":"10","author":"Stavrou","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2021.01.017_bib118","doi-asserted-by":"crossref","first-page":"9078","DOI":"10.1073\/pnas.1217399110","article-title":"Murine leukemia virus glycosylated Gag blocks apolipoprotein B editing complex 3 and cytosolic sensor access to the reverse transcription complex","volume":"110","author":"Stavrou","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.virol.2021.01.017_bib119","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nsmb.1744","article-title":"APOBEC3 proteins mediate the clearance of foreign DNA from human cells","volume":"17","author":"Stenglein","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.virol.2021.01.017_bib120","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1742-4690-2-37","article-title":"APOBEC3G & HTLV-1: inhibition without deamination","volume":"2","author":"Strebel","year":"2005","journal-title":"Retrovirology"},{"key":"10.1016\/j.virol.2021.01.017_bib121","doi-asserted-by":"crossref","first-page":"4858","DOI":"10.1073\/pnas.1009687108","article-title":"Somatic hypermutation of human mitochondrial and nuclear DNA by APOBEC3 cytidine deaminases, a pathway for DNA catabolism","volume":"108","author":"Suspene","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"6","key":"10.1016\/j.virol.2021.01.017_bib122","first-page":"3231","article-title":"Self-cytoplasmic DNA upregulates the mutator enzyme APOBEC3A leading to chromosomal DNA damage","volume":"45","author":"Suspene","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.virol.2021.01.017_bib123","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nrmicro1579","article-title":"The road to chromatin - nuclear entry of retroviruses","volume":"5","author":"Suzuki","year":"2007","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.virol.2021.01.017_bib124","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1096\/fj.07-088781","article-title":"Sole copy of Z2-type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV-1","volume":"23","author":"Tan","year":"2009","journal-title":"Faseb. J."},{"key":"10.1016\/j.virol.2021.01.017_bib125","doi-asserted-by":"crossref","first-page":"27753","DOI":"10.1074\/jbc.M110.102822","article-title":"Innate immune signaling induces high levels of TC-specific deaminase activity in primary monocyte-derived cells through expression of APOBEC3A isoforms","volume":"285","author":"Thielen","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2021.01.017_bib126","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/nature15400","article-title":"SERINC3 and SERINC5 restrict HIV-1 infectivity and are counteracted by Nef","volume":"526","author":"Usami","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.virol.2021.01.017_bib127","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1126\/science.1153201","article-title":"Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions","volume":"320","author":"Vartanian","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.virol.2021.01.017_bib128","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1515\/hsz-2013-0165","article-title":"Structural features of antiviral DNA cytidine deaminases","volume":"394","author":"Vasudevan","year":"2013","journal-title":"Biol. Chem."},{"key":"10.1016\/j.virol.2021.01.017_bib129","doi-asserted-by":"crossref","first-page":"3777","DOI":"10.1128\/JVI.06594-11","article-title":"The cellular antiviral protein APOBEC3G interacts with HIV-1 reverse transcriptase and inhibits its function during viral replication","volume":"86","author":"Wang","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2021.01.017_bib130","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1074\/jbc.M610150200","article-title":"Biochemical differentiation of APOBEC3F and APOBEC3G proteins associated with HIV-1 life cycle","volume":"282","author":"Wang","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.virol.2021.01.017_bib131","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/nbt.4198","article-title":"Efficient base editing in methylated regions with a human APOBEC3A-Cas9 fusion","volume":"36","author":"Wang","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.virol.2021.01.017_bib132","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1128\/JVI.02383-14","article-title":"APOBEC3A functions as a restriction factor of human papillomavirus","volume":"89","author":"Warren","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2021.01.017_bib133","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01318-17","article-title":"Human papillomavirus 16 E7 stabilizes APOBEC3A protein by inhibiting cullin 2-dependent protein degradation","volume":"92","author":"Westrich","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2021.01.017_bib134","doi-asserted-by":"crossref","first-page":"13694","DOI":"10.1128\/JVI.01646-07","article-title":"Inhibition of alpharetrovirus replication by a range of human APOBEC3 proteins","volume":"81","author":"Wiegand","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2021.01.017_bib135","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1038\/sj.emboj.7600246","article-title":"A second human antiretroviral factor, APOBEC3F, is suppressed by the HIV-1 and HIV-2 Vif proteins","volume":"23","author":"Wiegand","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.virol.2021.01.017_bib136","doi-asserted-by":"crossref","first-page":"9206","DOI":"10.1093\/nar\/gks685","article-title":"Efficient deamination of 5-methylcytosines in DNA by human APOBEC3A, but not by AID or APOBEC3G","volume":"40","author":"Wijesinghe","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.virol.2021.01.017_bib137","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nsmb758","article-title":"Single-strand specificity of APOBEC3G accounts for minus-strand deamination of the HIV genome","volume":"11","author":"Yu","year":"2004","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.virol.2021.01.017_bib138","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1126\/science.1089591","article-title":"Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex","volume":"302","author":"Yu","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.virol.2021.01.017_bib139","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1101\/gad.1250204","article-title":"Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines","volume":"18","author":"Yu","year":"2004","journal-title":"Genes Dev."},{"key":"10.1016\/j.virol.2021.01.017_bib140","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature01707","article-title":"The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA","volume":"424","author":"Zhang","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.virol.2021.01.017_bib141","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00032-20","article-title":"Murine leukemia virus P50 protein counteracts APOBEC3 by blocking its packaging","volume":"94","author":"Zhao","year":"2020","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2021.01.017_bib142","doi-asserted-by":"crossref","first-page":"7547","DOI":"10.1128\/JVI.00015-09","article-title":"Restriction of equine infectious anemia virus by equine APOBEC3 cytidine deaminases","volume":"83","author":"Zielonka","year":"2009","journal-title":"J. Virol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682221000337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682221000337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:53:39Z","timestamp":1758588819000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682221000337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":141,"alternative-id":["S0042682221000337"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2021.01.017","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Murine leukemia virus resists producer cell APOBEC3A by its Glycosylated Gag but not target cell APOBEC3A","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2021.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}